Ex vivo Manufactured Neutrophils for Treatment of Neutropenia—A Process Economic Evaluation

Neutropenia is a common side-effect of acute myeloid leukemia (AML) chemotherapy characterized by a critical drop in neutrophil blood concentration. Neutropenic patients are prone to infections, experience poorer clinical outcomes, and require expensive medical care. Although transfusions of donor n...

Descripción completa

Detalles Bibliográficos
Autores principales: Torres-Acosta, Mario A., Harrison, Richard P., Csaszar, Elizabeth, Rito-Palomares, Marco, Brunck, Marion E. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405517/
https://www.ncbi.nlm.nih.gov/pubmed/30881955
http://dx.doi.org/10.3389/fmed.2019.00021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405517/
https://www.ncbi.nlm.nih.gov/pubmed/30881955
http://dx.doi.org/10.3389/fmed.2019.00021

Ejemplares similares